Drug Discovery Outsourcing Market Analysis Report By Workflow (Lead Identification & Candidate Optimization, Preclinical Development), By Therapeutic Area, By Drug Type, And Segment Forecasts, 2018 - 2025

Published: Jun, 2018 | Pages: 175 | Publisher: Grand View Research
Industry: Pharmaceutical | Report Format: Electronic (PDF)

The global drug discovery outsourcing market size is expected to reach USD 4.44 billion by 2025 at an 8.14% CAGR, according to a new report by Grand View Research, Inc. Urging need to identify potential drug candidates for various chronic diseases is anticipated to fuel growth.

Technological advances in in silico drug designing and accelerating integration of Artificial Intelligence (AI) in drug discovery are driving industry progress. Multiple applications of AI algorithms in drug design and discovery provide opportunities for players to offer specialized drug discovery services. It is useful for processes such as target and compound selection, predictive analytics, screening, and drug repurposing.

Projected rise in adoption of outsourcing over the forecast period is expected to boost market revenue generation. Half of the drug discovery processes are anticipated to be outsourced, thereby creating massive opportunities for CROs, CMOs, and CDMOs to expand their market presence.

Number of collaborations among these organizations, key pharmaceutical players, and several universities has increased over the past few years. This rise in alliance further supports the projected increase in growth potential.

High cost and high risk of drug failure are major challenges faced in drug discovery. However, advances in technology that increase efficiency of drug discovery, coupled with increased adoption of highly advanced technology to provide specialized services, allow outsourcing companies to overcome these challenges.

Further key findings from the report suggest:

• Escalating incidence of respiratory disorders such as asthma and chronic obstructive pulmonary disease (COPD) is projected to indirectly propel market growth. Advancements in technologies, such as emergence of Artificial Intelligence (AI) in the pharmaceutical industry, is also anticipated to accelerate industry progress

• Moreover, increasing incidences of antibiotic resistance as well as drug resistance have improved focus on discovery of novel compounds to treat conditions such as Multidrug-Resistant TB (MDR-TB)

• Based on workflow, lead identification and candidate optimization is slated for impressive growth owing to high bottlenecks in this workflow segment

• By therapeutic area, oncology drug discovery outsourcing is fueled by increasing demand for oncology solutions, coupled with expanding government support in cancer research

• North America dominates the global market owing to high focus on R&D in identification of novel drug candidates, along with presence of key players

• Asia Pacific is projected to witness the fastest growth over the forecast period as a result of increasing number of CRO, CMOs, and CDMOs in emerging countries. Rising trend of outsourcing manufacturing and R&D activities to countries such as China and India will aid growth in the region

• Some of the major players are Charles River; EVOTEC, Laboratory Corporation of America Holdings; GenScript, Merck & Co., Inc.; Jubilant Biosys; Thermo Fisher Scientific, Inc.; Oncodesign; Albany Molecular Research, Inc.; WuXi AppTec; Dalton Pharma Services; Pharmaceutical Product Development, LLC; DiscoverX Corporation; and QIAGEN

• Collaboration of players with key pharmaceutical companies and academics and research centers is observed to increase in recent years.

 Table of Contents

Chapter 1 Research Methodology
                  1.1 Information Procurement
                  1.2 Data Analysis

Chapter 2 Executive Summary
                  2.1 Market Snapshot

Chapter 3 Drug Discovery Outsourcing Market: Variables, Trends & Scope
                  3.1 Market Segmentation &Scope
                      3.1.1 Market driver analysis
                          3.1.1.1 Increasing trends of partnerships in drug discovery research
                          3.1.1.2 Rising incidence rate of metabolic, genetic and other chronic diseases
                          3.1.1.3 Technology advancement in drug discovery
                      3.1.2 Market restraint analysis
                          3.1.2.1 High cost and high risk of drug failure
                  3.2 Penetration &Growth Prospect Mapping for Workflow, 2016
                  3.3 Drug Discovery Outsourcing - SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
                  3.4 Industry Analysis - Porter's

Chapter 4 Drug Discovery Outsourcing Market: Workflow Estimates & Trend Analysis
                  4.1 Global Drug Discovery Outsourcing Market: Workflow Movement Analysis
                  4.2 Target Identification & Screening
                      4.2.1 Global target identification & screening market, 2013 - 2025 (USD Million)
                  4.3 Target Validation & Functional Informatics
                      4.3.1 Global target validation & functional informatics market, 2013 - 2025 (USD Million)
                  4.4 Lead Identification & Candidate Optimization
                      4.4.1 Global lead identification & candidate optimization market, 2013 - 2025 (USD Million)
                  4.5 Preclinical Development
                      4.5.1 Global preclinical development market, 2013 - 2025 (USD Million)
                  4.6 Other Associated Workflow
                      4.6.1 Global other associated workflow market, 2013 - 2025 (USD Million)

Chapter 5 Drug Discovery Outsourcing Market: Therapeutic Area Estimates & Trend Analysis
                  5.1 Global Drug Discovery Outsourcing Market: Therapeutic Area Movement Analysis
                  5.2 Respiratory System Disorders
                      5.2.1 Global respiratory system disorders market, 2013 - 2025 (USD Million)
                  5.3 Pain and Anesthesia
                      5.3.1 Global pain and anesthesia market, 2013 - 2025 (USD Million)
                  5.4 Oncology Disorders
                      5.4.1 Global oncology disorders market, 2013 - 2025 (USD Million)
                  5.5 Ophthalmology Disorders
                      5.5.1 Global ophthalmology disorders market, 2013 - 2025 (USD Million)
                  5.6 Hematology Disorders
                      5.6.1 Global hematology disorders market, 2013 - 2025 (USD Million)
                  5.7 Cardiovascular Disorders
                      5.7.1 Global cardiovascular disorders market, 2013 - 2025 (USD Million)
                  5.8 Endocrine Disorders
                      5.8.1 Global endocrine disorders market, 2013 - 2025 (USD Million)
                  5.9 Gastrointestinal Disorders
                      5.9.1 Global gastrointestinal disorders market, 2013 - 2025 (USD Million)
                  5.10 Immunomodulation Disorders
                      5.10.1 Global immunomodulation disorders market, 2013 - 2025 (USD Million)
                  5.11 Anti-Infective
                      5.11.1 Global anti-infective market, 2013 - 2025 (USD Million)
                  5.12 Central Nervous System Disorders
                      5.12.1 Global central nervous system disorders market, 2013 - 2025 (USD Million)
                  5.13 Dermatology Disorders
                      5.13.1 Global dermatology disorders market, 2013 - 2025 (USD Million)
                  5.14 Genitourinary System Disorders
                      5.14.1 Global genitourinary system disorders market, 2013 - 2025 (USD Million)

Chapter 6 Drug Discovery Outsourcing Market: Drug Type Estimates & Trend Analysis
                  6.1 Global Drug Discovery Outsourcing Market: Drug Type Movement Analysis
                  6.2 Small Molecules
                      6.2.1 Global small molecules market, 2013 - 2025 (USD Million)
                  6.3 Large Molecules
                      6.3.1 Global large molecules market, 2013 - 2025 (USD Million)

Chapter 7 Drug Discovery Outsourcing Market: Regional Estimates & Trend Analysis by Workflow, Therapeutic Area, & Drug Type
                  7.1 Drug Discovery Outsourcing Market Share by Region, 2016 & 2025
                  7.2 North America
                      7.2.1 North America drug discovery outsourcing market, 2013 - 2025 (USD Million)
                      7.2.2 U.S.
                          7.2.2.1 U.S. drug discovery outsourcing market, by workflow, 2013 - 2025 (USD Million)
                          7.2.2.2 U.S. drug discovery outsourcing market, by therapeutic area, 2013 - 2025 (USD Million)
                          7.2.2.3 U.S. drug discovery outsourcing market, by drug type, 2013 - 2025 (USD Million)
                      7.2.3 Canada
                          7.2.3.1 Canada drug discovery outsourcing market, by workflow, 2013 - 2025 (USD Million)
                          7.2.3.2 Canada drug discovery outsourcing market, by therapeutic area, 2013 - 2025 (USD Million)
                          7.2.3.3 Canada drug discovery outsourcing market, by drug type, 2013 - 2025 (USD Million)
                  7.3 Europe
                      7.3.1 Europe drug discovery outsourcing market, 2013 - 2025 (USD Million)
                      7.3.2 Germany
                          7.3.2.1 Germany drug discovery outsourcing market, by workflow, 2013 - 2025 (USD Million)
                          7.3.2.2 Germany drug discovery outsourcing market, by therapeutic area, 2013 - 2025 (USD Million)
                          7.3.2.3 Germany drug discovery outsourcing market, by drug type, 2013 - 2025 (USD Million)
                      7.3.3 U.K.
                          7.3.3.1 U.K. drug discovery outsourcing market, by workflow, 2013 - 2025 (USD Million)
                          7.3.3.2 U.K. drug discovery outsourcing market, by therapeutic area, 2013 - 2025 (USD Million)
                          7.3.3.3 U.K. drug discovery outsourcing market, by drug type, 2013 - 2025 (USD Million)
                  7.4 Asia Pacific
                      7.4.1 Asia Pacific drug discovery outsourcing market, 2013 - 2025 (USD Million)
                      7.4.2 Japan
                          7.4.2.1 Japan drug discovery outsourcing market, by workflow, 2013 - 2025 (USD Million)
                          7.4.2.2 Japan drug discovery outsourcing market, by therapeutic area, 2013 - 2025 (USD Million)
                          7.4.2.3 Japan drug discovery outsourcing market, by drug type, 2013 - 2025 (USD Million)
                      7.4.3 China
                          7.4.3.1 China drug discovery outsourcing market, by workflow, 2013 - 2025 (USD Million)
                          7.4.3.2 China drug discovery outsourcing market, by therapeutic area, 2013 - 2025 (USD Million)
                          7.4.3.3 China drug discovery outsourcing market, by drug type, 2013 - 2025 (USD Million)
                  7.5 Latin America
                      7.5.1 Latin America drug discovery outsourcing market, 2013 - 2025 (USD Million)
                      7.5.2 Brazil
                          7.5.2.1 Brazil drug discovery outsourcing market, by workflow, 2013 - 2025 (USD Million)
                          7.5.2.2 Brazil drug discovery outsourcing market, by therapeutic area, 2013 - 2025 (USD Million)
                          7.5.2.3 Brazil drug discovery outsourcing market, by drug type, 2013 - 2025 (USD Million)
                  7.6 Middle East & Africa (MEA)
                      7.6.1 Middle East & Africa drug discovery outsourcing market, 2013 - 2025 (USD Million)
                      7.6.2 South Africa
                          7.6.2.1 South Africa drug discovery outsourcing market, by workflow, 2013 - 2025 (USD Million)
                          7.6.2.2 South Africa drug discovery outsourcing market, by therapeutic area, 2013 - 2025 (USD Million)
                          7.6.2.3 South Africa drug discovery outsourcing market, by drug type, 2013 - 2025 (USD Million)

Chapter 8 Competitive Landscape
                  8.1 Strategy Framework
                  8.2 Market Participation Categorization
                  8.3 Company Profiles
                      8.3.1 Albany Molecular Research Inc.
                          8.3.1.1 Company overview
                          8.3.1.2 Financial performance
                          8.3.1.3 Product benchmarking
                          8.3.1.4 Strategic initiatives
                      8.3.2 EVOTEC
                          8.3.2.1 Company overview
                              8.3.2.1.1 Cyprotex
                          8.3.2.2 Financial performance
                          8.3.2.3 Product benchmarking
                          8.3.2.4 Strategic initiatives
                      8.3.3 LabCorp
                          8.3.3.1 Company overview
                              8.3.3.1.1 Covance Inc.,
                          8.3.3.2 Financial performance
                          8.3.3.3 Product benchmarking
                          8.3.3.4 Strategic initiatives
                      8.3.4 GenScript
                          8.3.4.1 Company overview
                              8.3.4.1.1 Pharmaceutical Product Development, LLC.
                          8.3.4.2 Financial performance
                          8.3.4.3 Product benchmarking
                          8.3.4.4 Strategic initiatives
                      8.3.5 QuintilesIMS
                          8.3.5.1 Company overview
                          8.3.5.2 Financial performance
                          8.3.5.3 Product benchmarking
                          8.3.5.4 Strategic initiatives
                      8.3.6 Charles River
                          8.3.6.1 Company overview
                          8.3.6.2 Financial performance
                          8.3.6.3 Product benchmarking
                          8.3.6.4 Strategic initiatives
                      8.3.7 Aptuit LLC
                          8.3.7.1 Company overview
                          8.3.7.2 Financial performance
                          8.3.7.3 Product benchmarking
                          8.3.7.4 Strategic initiatives
                      8.3.8. WIL Research
                          8.3.8.1 Company overview
                          8.3.8.3 Financial performance
                          8.3.8.4 Product benchmarking
                          8.3.8.5 Strategic initiatives
                      8.3.9 Domainex
                          8.3.9.1 Company overview
                          8.3.9.2 Financial performance
                          8.3.9.3 Product benchmarking
                          8.3.9.4 Strategic initiatives
                      8.3.10 Selcia Ltd.
                          8.3.10.1 Company overview
                          8.3.10.2 Financial performance
                          8.3.10.3 Product benchmarking
                          8.3.10.4 Strategic initiatives
                      8.3.11 Viva Biotech Ltd.
                          8.3.11.1 Company overview
                          8.3.11.2 Financial performance
                          8.3.11.3 Product benchmarking
                          8.3.11.4 Strategic initiatives
                      8.3.12 WuXi AppTec
                          8.3.12.1 Company overview
                          8.3.12.2 Financial performance
                          8.3.12.3 Product benchmarking
                          8.3.12.4 Strategic initiatives
                      8.3.13 TGS Lifesciences Pvt Ltd.
                          8.3.13.1 Company overview
                          8.3.13.2 Financial performance
                          8.3.13.3 Product benchmarking
                          8.3.13.4 Strategic initiatives
                      8.3.14 Merck & Co., Inc.
                          8.3.14.1 Company overview
                              8.3.14.1.1 Sigma-Aldrich Co. LLC
                          8.3.14.2 Financial performance
                          8.3.14.3 Product benchmarking
                          8.3.14.4 Strategic initiatives
                      8.3.15 Thermo Fisher Scientific, Inc.
                          8.3.15.1 Company overview
                          8.3.15.2 Financial performance
                          8.3.15.3 Product benchmarking
                          8.3.15.4 Strategic initiatives
                      8.3.16 QIAGEN 
                          8.3.16.1 Company overview
                          8.3.16.2 Financial performance
                          8.3.16.3 Product benchmarking
                          8.3.16.4 Strategic initiatives
                      8.3.17 DiscoverX Corporation
                          8.3.17.1 Company overview
                          8.3.17.2 Financial performance
                          8.3.17.3 Product benchmarking
                          8.3.17.4 Strategic initiatives
                      8.3.18 Dalton Pharma Services
                          8.3.18.1 Company overview
                          8.3.18.2 Financial performance
                          8.3.18.3 Product benchmarking
                          8.3.18.4 Strategic initiatives
                      8.3.19 ONCODESIGN
                          8.3.19.1 Company overview
                          8.3.19.2 Financial performance
                          8.3.19.3 Product benchmarking
                          8.3.19.4 Strategic initiatives
                      8.3.20 Jubilant Biosys
                          8.3.20.1 Company overview
                          8.3.20.2 Financial performance
                          8.3.20.3 Product benchmarking
                          8.3.20.4 Strategic initiatives

List of Tables

TABLE 1 Integrated informatics and technology solutions for target validation in drug discovery
TABLE 2 Integrated informatics and technology solutions for lead identification and optimization in drug discovery
TABLE 3 Clinical pipeline of companies in oncology area
TABLE 4 North America drug discovery outsourcing market, by workflow, 2013 - 2025 (USD Million)
TABLE 5 North America drug discovery outsourcing market, by therapeutic area, 2013 - 2025 (USD Million)
TABLE 6 North America drug discovery outsourcing market, by drug type, 2013 - 2025 (USD Million)
TABLE 7 U.S. drug discovery outsourcing market, by workflow, 2013 - 2025 (USD Million)
TABLE 8 U.S. drug discovery outsourcing market, by therapeutic area, 2013 - 2025 (USD Million)
TABLE 9 U.S. drug discovery outsourcing market, by drug type, 2013 - 2025 (USD Million)
TABLE 10 Canada drug discovery outsourcing market, by workflow, 2013 - 2025 (USD Million)
TABLE 11 Canada drug discovery outsourcing market, by therapeutic area, 2013 - 2025 (USD Million)
TABLE 12 Canada drug discovery outsourcing market, by drug type, 2013 - 2025 (USD Million)
TABLE 13 Europe drug discovery outsourcing market, by workflow, 2013 - 2025 (USD Million)
TABLE 14 Europe drug discovery outsourcing market, by therapeutic area, 2013 - 2025 (USD Million)
TABLE 15 Europe drug discovery outsourcing market, by drug type, 2013 - 2025 (USD Million)
TABLE 16 Germany drug discovery outsourcing market, by workflow, 2013 - 2025 (USD Million)
TABLE 17 Germany drug discovery outsourcing market, by therapeutic area, 2013 - 2025 (USD Million)
TABLE 18 Germany drug discovery outsourcing market, by drug type, 2013 - 2025 (USD Million)
TABLE 19 U.K. drug discovery outsourcing market, by workflow, 2013 - 2025 (USD Million)
TABLE 20 U.K. drug discovery outsourcing market, by therapeutic area, 2013 - 2025 (USD Million)
TABLE 21 Germany drug discovery outsourcing market, by drug type, 2013 - 2025 (USD Million)
TABLE 22 Asia Pacific drug discovery outsourcing market, by workflow, 2013 - 2025 (USD Million)
TABLE 23 Asia Pacific drug discovery outsourcing market, by therapeutic area, 2013 - 2025 (USD Million)
TABLE 24 Asia Pacific drug discovery outsourcing market, by drug type, 2013 - 2025 (USD Million)
TABLE 25 Japan drug discovery outsourcing market, by workflow, 2013 - 2025 (USD Million)
TABLE 26 Japan drug discovery outsourcing market, by therapeutic area, 2013 - 2025 (USD Million)
TABLE 27 Japan drug discovery outsourcing market, by drug type, 2013 - 2025 (USD Million)
TABLE 28 China drug discovery outsourcing market, by workflow, 2013 - 2025 (USD Million)
TABLE 29 China drug discovery outsourcing market, by therapeutic area, 2013 - 2025 (USD Million)
TABLE 30 China drug discovery outsourcing market, by drug type, 2013 - 2025 (USD Million)
TABLE 31 Latin America drug discovery outsourcing market, by workflow, 2013 - 2025 (USD Million)
TABLE 32 Latin America drug discovery outsourcing market, by therapeutic area, 2013 - 2025 (USD Million)
TABLE 33 Latin America drug discovery outsourcing market, by drug type, 2013 - 2025 (USD Million)
TABLE 34 Brazil drug discovery outsourcing market, by workflow, 2013 - 2025 (USD Million)
TABLE 35 Brazil drug discovery outsourcing market, by therapeutic area, 2013 - 2025 (USD Million)
TABLE 36 Brazil drug discovery outsourcing market, by drug type, 2013 - 2025 (USD Million)
TABLE 37 Middle East & Africa (MEA) drug discovery outsourcing market, by workflow, 2013 - 2025 (USD Million)
TABLE 38 Middle East & Africa (MEA) drug discovery outsourcing market, by therapeutic area, 2013 - 2025 (USD Million)
TABLE 39 Middle East & Africa (MEA) drug discovery outsourcing market, by drug type, 2013 - 2025 (USD Million)
TABLE 40 South Africa drug discovery outsourcing market, by workflow, 2013 - 2025 (USD Million)
TABLE 41 South Africa drug discovery outsourcing market, by therapeutic area, 2013 - 2025 (USD Million)
TABLE 42 South Africa drug discovery outsourcing market, by drug type, 2013 - 2025 (USD Million)

List of Figures

FIG. 1 Market research process
FIG. 2 Information procurement
FIG. 3 Primary research pattern
FIG. 4 Market research approaches
FIG. 5 Value chain based sizing & forecasting
FIG. 6 QFD modelling for market share assessment
FIG. 7 Market summary
FIG. 8 Market trends & outlook
FIG. 9 Market segmentation & scope
FIG. 10 Market driver relevance analysis (Current & future impact)
FIG. 11 Deaths caused by major diseases in 2015
FIG. 12 Market restraint relevance analysis (Current & future impact)
FIG. 13 Penetration & growth prospect mapping for workflow, 2016
FIG. 14 SWOT analysis, by factor (political & legal, economic and technological)
FIG. 15 Porter's Five Forces Analysis
FIG. 16 Global drug discovery outsourcing market: Workflow outlook key takeaways
FIG. 17 Global drug discovery outsourcing market: Workflow movement analysis
FIG. 18 Global target identification & screening market, 2013 - 2025 (USD Million)
FIG. 19 Global target validation & functional informatics market, 2013 - 2025 (USD Million)
FIG. 20 Global lead identification & candidate optimization market, 2013 - 2025 (USD Million)
FIG. 21 Global preclinical development market, 2013 - 2025 (USD Million)
FIG. 22 Global other associated workflow market, 2013 - 2025 (USD Million)
FIG. 23 Global drug discovery outsourcing market: Therapeutic area estimates outlook key takeaways
FIG. 24 Global drug discovery Outsourcing market: Therapeutic Area movement analysis
FIG. 25 Global respiratory system disorders market, 2013 - 2025 (USD Million)
FIG. 26 Global pain and anesthesia market, 2013 - 2025 (USD Million)
FIG. 27 Global oncology disorders market, 2013 - 2025 (USD Million)
FIG. 28 Global ophthalmology disorders market, 2013 - 2025 (USD Million)
FIG. 29 Global hematology disorders market, 2013 - 2025 (USD Million)
FIG. 30 Global cardiovascular disorders market, 2013 - 2025 (USD Million)
FIG. 31 Global endocrine disorders market, 2013 - 2025 (USD Million)
FIG. 32 Global gastrointestinal disorders market, 2013 - 2025 (USD Million)
FIG. 33 Global immunomodulation disorders market, 2013 - 2025 (USD Million)
FIG. 34 Global anti-infective market, 2013 - 2025 (USD Million)
FIG. 35 Global central nervous system disorders market, 2013 - 2025 (USD Million)
FIG. 36 Global dermatology disorders market, 2013 - 2025 (USD Million)
FIG. 37 Global genitourinary system disorders market, 2013 - 2025 (USD Million)
FIG. 38 Global drug discovery Outsourcing market: Drug type outlook key takeaways
FIG. 39 Global drug discovery outsourcing market: drug type movement analysis
FIG. 40 Global small molecules market, 2013 - 2025 (USD Million)
FIG. 41 Global large molecules market, 2013 - 2025 (USD Million)
FIG. 42 Regional market place: Key takeaway
FIG. 43 Drug discovery outsourcing regional outlook, 2016 & 2025
FIG. 44 North America drug discovery outsourcing market, 2013 - 2025 (USD Million)
FIG. 45 U.S. drug discovery outsourcing market, 2013 - 2025 (USD Million)
FIG. 46 Canada drug discovery outsourcing market, 2013 - 2025 (USD Million)
FIG. 47 Europe drug discovery outsourcing market, 2013 - 2025 (USD Million)
FIG. 48 Germany drug discovery outsourcing market, 2013 - 2025 (USD Million)
FIG. 49 U.K. drug discovery outsourcing market, 2013 - 2025 (USD Million)
FIG. 50 Asia Pacific drug discovery outsourcing market, 2013 - 2025 (USD Million)
FIG. 51 Japan drug discovery outsourcing market, 2013 - 2025 (USD Million)
FIG. 52 China drug discovery outsourcing market, 2013 - 2025 (USD Million)
FIG. 53 Latin America drug discovery outsourcing market, 2013 - 2025 (USD Million)
FIG. 54 Brazil drug discovery outsourcing market, 2013 - 2025 (USD Million)
FIG. 55 Middle East & Africa drug discovery outsourcing market, 2013 - 2025 (USD Million)
FIG. 56 South Africa drug discovery outsourcing market, 2013 - 2025 (USD Million)
FIG. 57 Strategy framework
FIG. 58 Participant categorization